{"count": 12, "results": [{"_id": "34708800", "pmid": 34708800, "pmcid": "PMC8725087", "title": "Association of metformin use among diabetics and the incidence of primary open-angle glaucoma - The Chennai Eye Disease Incidence Study", "journal": "Indian J Ophthalmol", "authors": ["George R", "Asokan R", "Vijaya L"], "date": "2021-11-01T00:00:00Z", "doi": "10.4103/ijo.IJO_1486_21", "meta_date_publication": "2021 Nov", "meta_volume": "69", "meta_issue": "11", "meta_pages": "3336-3338", "score": 50277.336, "text_hl": "Usage of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ was not found to be associated with incident @<m>DISEASE_Glaucoma_Open_Angle</m> @DISEASE_MESH:D005902 @@@POAG@@@.", "citations": {"NLM": "George R, Asokan R, Vijaya L. Association of metformin use among diabetics and the incidence of primary open-angle glaucoma - The Chennai Eye Disease Incidence Study Indian J Ophthalmol. 2021 Nov;69(11):3336-3338. PMID: 34708800", "BibTeX": "@article{34708800, title={Association of metformin use among diabetics and the incidence of primary open-angle glaucoma - The Chennai Eye Disease Incidence Study}, author={George R and Asokan R and Vijaya L}, journal={Indian J Ophthalmol}, volume={69}, number={11}, pages={3336-3338}}"}}, {"_id": "40940077", "pmid": 40940077, "title": "Association of metformin use with primary open-angle glaucoma using data from the National Institutes of Health All of Us Program.", "journal": "BMJ Open Ophthalmol", "authors": ["Sidhu S", "Radha Saseendrakumar B", "Varkhedi V", "Wu JH", "Parikh A", "Nudleman E", "Do JL", "Moghimi S", "Weinreb RN", "Baxter SL"], "date": "2025-09-12T00:00:00Z", "doi": "10.1136/bmjophth-2024-002027", "meta_date_publication": "2025 Sep 12", "meta_volume": "10", "meta_issue": "1", "meta_pages": "", "score": 50266.87, "text_hl": "Association of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ use with @<m>DISEASE_Glaucoma_Open_Angle</m> @DISEASE_MESH:D005902 @@@primary open-angle glaucoma@@@ using data from the National Institutes of Health All of Us Program.", "citations": {"NLM": "Sidhu S, Radha Saseendrakumar B, Varkhedi V, Wu JH, Parikh A, Nudleman E, Do JL, Moghimi S, Weinreb RN, Baxter SL. Association of metformin use with primary open-angle glaucoma using data from the National Institutes of Health All of Us Program. BMJ Open Ophthalmol. 2025 Sep 12;10(1):. PMID: 40940077", "BibTeX": "@article{40940077, title={Association of metformin use with primary open-angle glaucoma using data from the National Institutes of Health All of Us Program.}, author={Sidhu S and Radha Saseendrakumar B and Varkhedi V and Wu JH and Parikh A and Nudleman E and Do JL and Moghimi S and Weinreb RN and Baxter SL}, journal={BMJ Open Ophthalmol}, volume={10}, number={1}}"}}, {"_id": "35068220", "pmid": 35068220, "title": "Metformin and retinal diseases in preclinical and clinical studies: Insights and review of literature.", "journal": "Exp Biol Med (Maywood)", "authors": ["Amin SV", "Khanna S", "Parvar SP", "Shaw LT", "Dao D", "Hariprasad SM", "Skondra D"], "date": "2022-02-01T00:00:00Z", "doi": "10.1177/15353702211069986", "meta_date_publication": "2022 Feb", "meta_volume": "247", "meta_issue": "4", "meta_pages": "317-329", "score": 50261.85, "text_hl": "We then explore the sparse but promising retrospective clinical data on @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@'s potential protective role in @DISEASE_Diabetic_Retinopathy @DISEASE_MESH:D003930 @@@DR@@@, @DISEASE_Macular_Degeneration @DISEASE_MESH:D008268 @@@AMD@@@, @<m>DISEASE_Glaucoma_Open_Angle</m> @DISEASE_MESH:D005902 @@@POAG@@@, and @DISEASE_Uveitis @DISEASE_MESH:D014605 @@@uveitis@@@. ", "citations": {"NLM": "Amin SV, Khanna S, Parvar SP, Shaw LT, Dao D, Hariprasad SM, Skondra D. Metformin and retinal diseases in preclinical and clinical studies: Insights and review of literature. Exp Biol Med (Maywood). 2022 Feb;247(4):317-329. PMID: 35068220", "BibTeX": "@article{35068220, title={Metformin and retinal diseases in preclinical and clinical studies: Insights and review of literature.}, author={Amin SV and Khanna S and Parvar SP and Shaw LT and Dao D and Hariprasad SM and Skondra D}, journal={Exp Biol Med (Maywood)}, volume={247}, number={4}, pages={317-329}}"}}, {"_id": "40372117", "pmid": 40372117, "title": "Association Between Long-Term Metformin Use and Risk of Open-Angle Glaucoma in Patients With Diabetes Mellitus.", "journal": "J Glaucoma", "authors": ["Huang SW", "Lai YR", "Yang Y", "Gau SY", "Chung NJ", "Tsai TH", "Huang KH", "Lee CY"], "date": "2025-05-16T00:00:00Z", "doi": "10.1097/IJG.0000000000002597", "meta_date_publication": "2025 May 16", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50261.24, "text_hl": "...PRCIS: @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ use wasn't dose-dependently linked to @<m>DISEASE_Glaucoma_Open_Angle</m> @DISEASE_MESH:D005902 @@@open-angle glaucoma@@@. ", "citations": {"NLM": "Huang SW, Lai YR, Yang Y, Gau SY, Chung NJ, Tsai TH, Huang KH, Lee CY. Association Between Long-Term Metformin Use and Risk of Open-Angle Glaucoma in Patients With Diabetes Mellitus. J Glaucoma. 2025 May 16;():. PMID: 40372117", "BibTeX": "@article{40372117, title={Association Between Long-Term Metformin Use and Risk of Open-Angle Glaucoma in Patients With Diabetes Mellitus.}, author={Huang SW and Lai YR and Yang Y and Gau SY and Chung NJ and Tsai TH and Huang KH and Lee CY}, journal={J Glaucoma}}"}}, {"_id": "38316664", "pmid": 38316664, "title": "Association between metformin use and the risk of developing open-angle glaucoma among patients with diabetes: a retrospective cohort study and meta-analysis.", "journal": "Int Ophthalmol", "authors": ["Kim HK", "Lee W", "Ryu IH", "Kim JK", "Kim H", "Yoo TK"], "date": "2024-02-05T00:00:00Z", "doi": "10.1007/s10792-024-02945-w", "meta_date_publication": "2024 Feb 5", "meta_volume": "44", "meta_issue": "1", "meta_pages": "6", "score": 50260.59, "text_hl": "In this study, we investigated the association between @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ use and @<m>DISEASE_Glaucoma_Open_Angle</m> @DISEASE_MESH:D005902 @@@OAG@@@. ", "citations": {"NLM": "Kim HK, Lee W, Ryu IH, Kim JK, Kim H, Yoo TK. Association between metformin use and the risk of developing open-angle glaucoma among patients with diabetes: a retrospective cohort study and meta-analysis. Int Ophthalmol. 2024 Feb 5;44(1):6. PMID: 38316664", "BibTeX": "@article{38316664, title={Association between metformin use and the risk of developing open-angle glaucoma among patients with diabetes: a retrospective cohort study and meta-analysis.}, author={Kim HK and Lee W and Ryu IH and Kim JK and Kim H and Yoo TK}, journal={Int Ophthalmol}, volume={44}, number={1}, pages={6}}"}}, {"_id": "39182626", "pmid": 39182626, "title": "Comparative Effects of GLP-1 Receptor Agonists and Metformin on Glaucoma Risk in Type 2 Diabetes Patients.", "journal": "Ophthalmology", "authors": ["Muayad J", "Loya A", "Hussain ZS", "Chauhan MZ", "Alsoudi AF", "De Francesco T", "Ike K Ahmed I"], "date": "2024-08-23T00:00:00Z", "doi": "10.1016/j.ophtha.2024.08.023", "meta_date_publication": "2024 Aug 23", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50255.824, "text_hl": "@SPECIES_9606 @@@Patients@@@ treated with GLP-1 receptor agonists had a significantly decreased risk of developing @<m>DISEASE_Glaucoma_Open_Angle</m> @DISEASE_MESH:D005902 @@@POAG@@@ compared to those on @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ at 1 year (RR 0.59, 95% CI 0.39-0.88), 2 years (RR 0.50, 95% CI 0.32-0.78), and 3 years (RR 0.59, 95% CI 0.37-0.94). ", "citations": {"NLM": "Muayad J, Loya A, Hussain ZS, Chauhan MZ, Alsoudi AF, De Francesco T, Ike K Ahmed I. Comparative Effects of GLP-1 Receptor Agonists and Metformin on Glaucoma Risk in Type 2 Diabetes Patients. Ophthalmology. 2024 Aug 23;():. PMID: 39182626", "BibTeX": "@article{39182626, title={Comparative Effects of GLP-1 Receptor Agonists and Metformin on Glaucoma Risk in Type 2 Diabetes Patients.}, author={Muayad J and Loya A and Hussain ZS and Chauhan MZ and Alsoudi AF and De Francesco T and Ike K Ahmed I}, journal={Ophthalmology}}"}}, {"_id": "34708801", "pmid": 34708801, "pmcid": "PMC8725086", "title": "Commentary - Association of metformin use among diabetics and the incidence of primary open-angle glaucoma - The Chennai Eye Disease Incidence Study", "journal": "Indian J Ophthalmol", "authors": ["Kumar N"], "date": "2021-11-01T00:00:00Z", "doi": "10.4103/ijo.IJO_1963_21", "meta_date_publication": "2021 Nov", "meta_volume": "69", "meta_issue": "11", "meta_pages": "3339-3340", "score": 50255.33, "text_hl": "In their study, the administration of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ did not halt the progression of @<m>DISEASE_Glaucoma_Open_Angle</m> @DISEASE_MESH:D005902 @@@POAG@@@. ", "citations": {"NLM": "Kumar N. Commentary - Association of metformin use among diabetics and the incidence of primary open-angle glaucoma - The Chennai Eye Disease Incidence Study Indian J Ophthalmol. 2021 Nov;69(11):3339-3340. PMID: 34708801", "BibTeX": "@article{34708801, title={Commentary - Association of metformin use among diabetics and the incidence of primary open-angle glaucoma - The Chennai Eye Disease Incidence Study}, author={Kumar N}, journal={Indian J Ophthalmol}, volume={69}, number={11}, pages={3339-3340}}"}}, {"_id": "35587864", "pmid": 35587864, "title": "Association of Diabetes Medication With Open-Angle Glaucoma, Age-Related Macular Degeneration, and Cataract in the Rotterdam Study.", "journal": "JAMA Ophthalmol", "authors": ["Vergroesen JE", "Thee EF", "Ahmadizar F", "van Duijn CM", "Stricker BH", "Kavousi M", "Klaver CCW", "Ramdas WD"], "date": "2022-07-01T00:00:00Z", "doi": "10.1001/jamaophthalmol.2022.1435", "meta_date_publication": "2022 Jul 1", "meta_volume": "140", "meta_issue": "7", "meta_pages": "674-681", "score": 50254.707, "text_hl": "@DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@T2D@@@ treated with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ was associated with a lower risk of @<m>DISEASE_Glaucoma_Open_Angle</m> @DISEASE_MESH:D005902 @@@OAG@@@ (OR, 0.18; 95% CI, 0.08-0.41; P < .001). ", "citations": {"NLM": "Vergroesen JE, Thee EF, Ahmadizar F, van Duijn CM, Stricker BH, Kavousi M, Klaver CCW, Ramdas WD. Association of Diabetes Medication With Open-Angle Glaucoma, Age-Related Macular Degeneration, and Cataract in the Rotterdam Study. JAMA Ophthalmol. 2022 Jul 1;140(7):674-681. PMID: 35587864", "BibTeX": "@article{35587864, title={Association of Diabetes Medication With Open-Angle Glaucoma, Age-Related Macular Degeneration, and Cataract in the Rotterdam Study.}, author={Vergroesen JE and Thee EF and Ahmadizar F and van Duijn CM and Stricker BH and Kavousi M and Klaver CCW and Ramdas WD}, journal={JAMA Ophthalmol}, volume={140}, number={7}, pages={674-681}}"}}, {"_id": "37037464", "pmid": 37037464, "pmcid": "PMC10085733", "title": "Novel potential drugs for the treatment of primary open-angle glaucoma using protein-protein interaction network analysis", "journal": "Genomics Inform", "authors": ["Zavarzadeh PG", "Abedi Z"], "date": "2023-03-01T00:00:00Z", "doi": "10.5808/gi.22070", "meta_date_publication": "2023 Mar", "meta_volume": "21", "meta_issue": "1", "meta_pages": "e6", "score": 50251.742, "text_hl": "Nevertheless, as with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin hydrochloride@@@, no specific information is available, particularly regarding the role of @CHEMICAL_ixazomib @CHEMICAL_MESH:C548400 @@@ixazomib citrate@@@ in @<m>DISEASE_Glaucoma_Open_Angle</m> @DISEASE_MESH:D005902 @@@POAG@@@.", "citations": {"NLM": "Zavarzadeh PG, Abedi Z. Novel potential drugs for the treatment of primary open-angle glaucoma using protein-protein interaction network analysis Genomics Inform. 2023 Mar;21(1):e6. PMID: 37037464", "BibTeX": "@article{37037464, title={Novel potential drugs for the treatment of primary open-angle glaucoma using protein-protein interaction network analysis}, author={Zavarzadeh PG and Abedi Z}, journal={Genomics Inform}, volume={21}, number={1}, pages={e6}}"}}, {"_id": "36598818", "pmid": 36598818, "pmcid": "PMC9812404", "title": "Metformin protects trabecular meshwork against oxidative injury via activating integrin/ROCK signals", "journal": "Elife", "authors": ["Xu L", "Zhang X", "Zhao Y", "Gang X", "Zhou T", "Han J", "Cao Y", "Qi B", "Song S", "Wang X", "Liang Y"], "date": "2023-01-04T00:00:00Z", "doi": "10.7554/eLife.81198", "meta_date_publication": "2023 Jan 4", "meta_volume": "12", "meta_issue": "", "meta_pages": "", "score": 50251.496, "text_hl": "This study provides new insights into @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ use and preclinical evidence for the potential treatment of @<m>DISEASE_Glaucoma_Open_Angle</m> @DISEASE_MESH:D005902 @@@primary open-angle glaucoma@@@.", "citations": {"NLM": "Xu L, Zhang X, Zhao Y, Gang X, Zhou T, Han J, Cao Y, Qi B, Song S, Wang X, Liang Y. Metformin protects trabecular meshwork against oxidative injury via activating integrin/ROCK signals Elife. 2023 Jan 4;12():. PMID: 36598818", "BibTeX": "@article{36598818, title={Metformin protects trabecular meshwork against oxidative injury via activating integrin/ROCK signals}, author={Xu L and Zhang X and Zhao Y and Gang X and Zhou T and Han J and Cao Y and Qi B and Song S and Wang X and Liang Y}, journal={Elife}, volume={12}}"}}]}